Ancillare Enhances Cold Chain Management Services for Clinical Trial Supplies

January 29, 2025 04:00 PM AEDT | By EIN Presswire
 Ancillare Enhances Cold Chain Management Services for Clinical Trial Supplies
Image source: EIN Presswire
HORSHAM, PA, UNITED STATES, January 29, 2025 /EINPresswire.com/ -- Ancillare, the global leader in clinical trial supply chain solutions, is pleased to announce the launch of its state-of-the-art Cold Chain Management services, specifically designed to ensure the safe handling and transport of temperature-sensitive supplies and equipment in clinical trials.

Recognizing the critical nature of temperature-sensitive products in clinical research, Ancillare is committed to maintaining precise refrigerated temperatures throughout the entire supply chain. This new service offering extends beyond transportation; it includes sourcing of the item, customs clearances, monitoring product expiry, and providing robust inventory management. These features are designed to guarantee the highest standards of quality, integrity and efficiency throughout the supply chain.

“Our enhanced Cold Chain Management services are a testament to Ancillare’s commitment to innovation and excellence in the clinical trial supply chain,” said Dr. Joanne Santomauro, CEO at Ancillare. “By offering a fully integrated approach that covers every aspect of the process - from sourcing to handling, storage, and transportation - we ensure that all products remain in optimal condition, while meeting stringent global regulatory requirements. This enables our Sponsors to avoid delays and disruptions that could negatively impact clinical trials.”

Ancillare’s comprehensive cold chain services help Sponsors achieve significant cost savings, optimize resource allocation, reduce risks, and improve overall coordination throughout the supply chain.

For more information about Ancillare and its Cold Chain Management services, visit ancillare.com or contact us.

About Ancillare
Ancillare is a full-service clinical trial supply partner that Life Sciences companies of all sizes, and at all development stages, rely on. From startup to closeout, and from supply sourcing to equipment reclamation and study disposition, we are the pioneers in clinical trial ancillary supply consulting and management, experienced in the full spectrum of clinical trial life cycle variables.

The Ancillare Team leverages extensive global buying power, a vast depot network, and subject-matter experts in research, procurement, operations, logistics, and regulatory matters to create tailored clinical supply and equipment programs for the most demanding Phase I-IV clinical research.

We help executives achieve better operational efficiency at all levels of the trial value chain. Simplifying and streamlining supply processes —that's our specialty. Reduced costs. Expedited cycle times. Risk well-managed. The benefits are measurable, but the results are invaluable.

To learn more, visit us at ancillare.com

Courtney Wright
Ancillare, LP
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.